(Q39530519)

English

Analysis of severe hepatic events associated with nevirapine-containing regimens: CD4+ T-cell count and gender in hepatitis C seropositive and seronegative patients

scientific article published on January 2007

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Analysis of severe hepatic events associated with nevirapine-containing regimens: CD4+ T-cell count and gender in hepatitis C seropositive and seronegative patients (English)

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Eugenia Quiros-Roldan

4

object named as

Eugenia Quiros-Roldan

0 references

author name string

Carlo Torti

1

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Silvia Costarelli

2

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Annalisa De Silvestri

3

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Giuseppe Lapadula

5

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Giuliana Cologni

6

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Giuseppe Paraninfo

7

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Filippo Castelnuovo

8

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Massimo Puoti

9

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Giampiero Carosi

10

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

BHCC Study Group

11

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

publication date

1 January 2007

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

30

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

12

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

1161-1169

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Drug-induced liver injury

1 reference

https://pubmed.ncbi.nlm.nih.gov/18035868

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Managing Antiretroviral-Associated Liver Disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/18035868

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-Term Safety and Efficacy of Nevirapine-Based Approaches in HIV Type 1-Infected Patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/18035868

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hepatotoxicity associated with nevirapine use.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18035868

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Sex differences in antiretroviral therapy-associated intolerance and adverse events

1 reference

https://pubmed.ncbi.nlm.nih.gov/18035868

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hepatotoxicity in HIV-1-infected patients receiving nevirapine-containing antiretroviral therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/18035868

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prospective, open-label comparative study of liver toxicity in an unselected population of HIV-infected patients treated for the first time with efavirenz or nevirapine

1 reference

https://pubmed.ncbi.nlm.nih.gov/18035868

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Incidence and risk factors for liver enzyme elevation during highly active antiretroviral therapy in HIV-HCV co-infected patients: results from the Italian EPOKA-MASTER Cohort

1 reference

https://pubmed.ncbi.nlm.nih.gov/18035868

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hepatitis C virus-associated hepatitis following treatment of HIV-infected patients with HIV protease inhibitors: an immune restoration disease?

1 reference

https://pubmed.ncbi.nlm.nih.gov/18035868

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Nevirapine toxicity in a cohort of HIV-1-infected pregnant women

1 reference

https://pubmed.ncbi.nlm.nih.gov/18035868

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A comprehensive hepatic safety analysis of nevirapine in different populations of HIV infected patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/18035868

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hepatotoxicity associated with nevirapine or efavirenz-containing antiretroviral therapy: role of hepatitis C and B infections

1 reference

https://pubmed.ncbi.nlm.nih.gov/18035868

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Changes in nevirapine plasma concentrations over time and its relationship with liver enzyme elevations

1 reference

https://pubmed.ncbi.nlm.nih.gov/18035868

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of first-line antiretroviral therapy with regimens including nevirapine, efavirenz, or both drugs, plus stavudine and lamivudine: a randomised open-label trial, the 2NN Study

1 reference

https://pubmed.ncbi.nlm.nih.gov/18035868

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Risk of discontinuation of nevirapine due to toxicities in antiretroviral-naive and -experienced HIV-infected patients with high and low CD4+ T-cell counts.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18035868

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Validation and comparison of indexes for fibrosis and cirrhosis prediction in chronic hepatitis C patients: proposal for a pragmatic approach classification without liver biopsies

1 reference

https://pubmed.ncbi.nlm.nih.gov/18035868

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Drug-induced liver injury associated with the use of nonnucleoside reverse-transcriptase inhibitors

1 reference

https://pubmed.ncbi.nlm.nih.gov/18035868

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The effect of baseline CD4 cell count and HIV-1 viral load on the efficacy and safety of nevirapine or efavirenz-based first-line HAART.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18035868

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Nevirapine versus efavirenz in 742 patients: no link of liver toxicity with female sex, and a baseline CD4 cell count greater than 250 cells/microl.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18035868

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.2165/00002018-200730120-00008

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39530519&oldid=2202956025"